Tocolysis: Indications and contraindications. When to start and when to stop;Tocolyse: Indications et contre-indications - Quand commencer? Quand arrêter?

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 31, Issue 7 SUPPL., 2002, Pages

  D'Ercole, C ^a   Bretelle, F ^b   Shojai, R ^a   Desbriere, R ^a   Boubli, L ^a  

^a HÔPITAL NORD   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Pregnancy; Premature delivery; Tocolysis

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN ANTAGONIST; PLACEBO; RITODRINE; TERBUTALINE;

AMNION FLUID; CLINICAL TRIAL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FETUS LUNG MATURATION; GESTATIONAL AGE; HUMAN; INTRAPARTUM HEMORRHAGE; MATERNAL DISEASE; META ANALYSIS; PLACENTA PREVIA; PREMATURE LABOR; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TOCOLYSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UTERINE CERVIX DILATATION;

CLINICAL TRIALS; FEMALE; FRANCE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PRACTICE GUIDELINES; PREGNANCY; PROGNOSIS; TOCOLYSIS; TOCOLYTIC AGENTS; TREATMENT OUTCOME; VASOTOCIN;

EID: 0036856742     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Spellacy WN, Cruz AC, Birk SA, Buhi WC. Treatment of premature labor with ritodrine: A randomized controlled study. Obstet Gynecol 1979; 54: 220-3.
2. Howard TE Jr, Killam AP, Penney LL, Daniell WC. A double blind randomized study of terbutaline in premature labor. Mil Med 1982; 147: 305-7.
3. Larsen JF, Hansen MK, Hesseldahl H, Kristoffersen K, Larsen PK, Osler M, et al. Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol 1980; 87: 949-57.
4. Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. J Reprod Med 1984; 29: 92-7.
5. Wesselius-de Casparis A, Thiery M, Yo le Sian A, Baumgarten K, Brosens I, Gamisans O, et al. 7 Results of double-blind, multicentre study with ritodrine in premature labour. Br Med J 1971; 767: 144-7.
6. Ingemarsson I. Effect of terbutaline on premature labor. A double-blind placebo-controlled study. Am J Obstet Gynecol 1976; 125: 520-4.
7. Larsen JF, Eldon K, Lange AP, Leegaard M, Osler M, Olsen JS, et al. Ritodrine in the treatment of preterm labor: Second Danish multicenter study. Obstet Gynecol 1986; 67: 607-13.
8. Leveno KJ, Klein VR, Guzick DS, Young DC, Hankins GD, Williams ML. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986; 1: 1293-6.
9. The Canadian preterm labor investigators group treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308-12
10. Schiff E, Sivan E, Terry S, Dulitzky M, Friedman SA, Mashiach S, et al. Currently recommended oral regimens for ritodrine tocolysis result in extremely low plasma levels. Am J Obstet Gynecol 1993; 169: 1059-64.
11. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labor: A meta-analysis. Obstet Gynecol 1995; 85: 313-7.
12. How HY, Hughes SA, Vogel RL, Gall SA, Spinnato JA. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 1995; 173: 1518-22.
13. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996; 175: 838-42.
14. Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996; 175: 834-7.
15. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: A meta-analysis. Am J Obstet Gynecol 1999; 181: 484-90.
16. Creasy RK, Golbus MS, Laros RK, Parer JT, Roberts JM. Oral ritrodine maintenance in the treatment of preterm labour. Am J Obstet Gynecol 1980; 137: 212-7.
17. Holleboom CA, Merkus JM, van Elferen LW, Keirse MJ. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol 1996; 103: 702-5.
18. Wenstrom KD, Weiner CP, Merrill D, Niebyl J. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol 1997; 14: 87-91.
19. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: A double-blind trial. Am J Obstet Gynecol 1998; 179: 874-8.
20. Michel MC, Pingsmann A, Nohlen M, Siekmann U, Brodde OE. Decreased myometrial beta-adrenoceptors in women receiving beta 2-adrenergic tocolytic therapy: Correlation with lymphocyte beta-adrenoceptors. Clin Pharmacol Ther 1989; 45: 1-8.
21. Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: A randomized clinical trial. Am J Obstet Gynecol 1999; 181: 822-7.
22. Macones GA, Sehdev HM, Berlin M, Morgan MA, Berlin JA. Evidence for magnesium sulfate as a tocolytic agent. Obstet Gynecol Surv 1997; 52: 652-8.
23. Smith GN, Walker MC, McGrath MJ. Randomized, double-blind placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynaecol 1999; 106: 736-9.
24. Leszczynska-Gorzelak B, Laskowska M, Marciniak B, Oleszczuk J. Nitric oxide for treatment of threatened preterm labor. Int J Gynaecol Obstet 2001; 73: 201-6.
25. Rowlands S, Trudinger B, Visva-Lingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate, a nitric oxide donor. Aust N Z J Obstet Gynaecol 1996; 36: 377-81.
26. Gabriel R, Treisser A. Traitement du travail prématuré. J Gynecol Obstet Biol Reprod 2001; 30: 3S9-3S19.
27. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980; 136: 1014-9.
28. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II. Double-blind study. J Perinat Med 1984; 12: 25-8.
29. Panter K, Hannah M, Amankwa K, Ohlsson A, Jeffries A, Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: A randomized placebo-controlled trial. Br J Obstet Gynaecol 1999; 106: 467-73.
30. Keirse M. Indomethacin tocolysis in preterm labour. In: Enkin M, Keirse M, Renfrew M, Neilson J, editors. Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. London: BMJ Publishing Group; 1995.
31. Spearing G. Alcohol, indomethacin and salbutamol. A comparative trial of their use in preterm labor. Obstet Gynecol 1979; 53: 171-4.
32. Katz Z, Lancet M, Yemini M, Mogilner B, Feigl A, Hur HB. Treatment of premature labor contractions with combined ritodrine and indomethacin. Int J Gynaecol Obstet 1983; 21: 337.
33. Gamissans O, Canas E, Cararach V, Ribas J, Puerto B, Edo A. A study of indomethacin combined with ritodrine in threatened preterm labour. Eur J Obstet Gynecol Reprod Biol 1978; 8: 123-8.
34. Carlan SJ, O'Brien, WF, Jones MH, O'Leary TD, Mastrogiannis D. Randomizes comparative trial of indomethacine and Sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79: 223-8.
35. Carlan SJ, O'Brien, WF, Jones MH, O'Leary TD, Roth L. Out-patient oral sulindac to prevent recurrence of preterm labor. Obstet Gynecol 1995; 85: 769-74.
36. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of oxytocin antagonist atosiban on preterm uterine activity in human. Am J Obstet Gynecol 1994; 170: 474-8.
37. Romero R, Sibai B, Sanchez-Ramos L, Valenzuela G, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatement of pretrem labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173-83.
38. Valenzuela G, Sanchez-Ramos L, Romero R, Silver H, Koltun W, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am J Obstet Gynecol 2000; 182: 1184-90.
39. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: A systematic review. Obstet Gynecol 1999; 94: 869-77.
40. Handwerker SM, Tejani NA, Verma UL, Archbald F. Correlation of maternal serum C-reactive protein with outcome of tocolysis. Obstet Gynecol 1984; 63: 220-4.
41. Cammu H, Gossens A, Derde MP, Temmermen M, Foulon W, Amy JJ. C-reactive protein in preterm labour: Association with outcome tocolysis and placental histology. Br J Obstet Gynaecol 1989; 86: 314-9.
42. Spinillo A, Capuzzo E, Stronati M, Ometto A, De Santolo A, Acciano S. Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol 1998; 105: 865-71.
43. Besinger RE, Moniak CW, Paskiewicz LS, Fishes SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta praevia. Am J Obstet Gynecol 1995; 172: 1770-8.
44. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third trimester bleeding? Am J Obstet Gynecol 1999; 180: 1572-8.
45. Gluck L, Kulovich MV, Borer RC, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971; 109: 440-5.
46. Dubin SB. Characterization of amniotic fluid lamellar bodies by resistive-pulse counting: Relationship to measures of fetal lung maturity. Clin Chem 1989; 35: 612-6.
47. Wijnberger LDE, Huijes AJM, Voorbij HAM, Franx A, Bruinse HW, Mol BWJ. The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: A meta-analysis. Br J Obstet Gynaecol 2001; 108: 583-8.
48. Neerhof MG, Haney EI, Silver RK, Ashwood ER, Lee I, Piazze JJ. Lamellar body count compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001; 97: 305-9.
49. Richarsdson DK, Heffner LJ. Fetal lung maturity: Test mature, interpretation not. Lancet 2001; 358: 684-6.
50. o: 206.
51. National Institutes of Health. Effect of cortocosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994; 12: 1-24.
52. Jones SC, Brost BC, Brehm WT. Should intravenous tocolysis be considered beyond 34 weeks' gestation? Am J Obstet Gynecol 2000; 183: 356-60.
53. Konte JM, Holbrook RH, Laros RK, Creasy RK. Short term neonatal morbidity associated with prematurity and the effectt of a prematurity prevention program on expected incidence of morbidity. Am J Perinatol 1986; 3: 283-8.
54. Robertson PA, Sniderman SH, Laros RK, Cowan R, Heilbron D, Goldenberg RL, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol 1992; 166: 1629-45.
55. Lewis DF, Futayyeh S, Towers CV, Asrat T, Edward MS, Brooks GG. Preterm delivery from 34 to 37 weeks of gestation: Is respiratory distress syndrom a problem? Am J Obstet Gynecol 1996; 174: 525-8.
56. Myers ER, Alvarez JG, Richardson DK, Ludmir J. Cost-effectiveness of fetal lung maturity testing in preterm labor. Obstet Gynecol 1997; 90: 824-9.
57. Macones GA, Bader TJ, Asch DA. Optimising maternal-fetal outcomes in preterm labor: A decision analysios. Br J Obstet Gynaecol 1998; 15: 541-50.
58. Amon E, Midkiff C, Winn H, Holcomb W, Shumway J, Artal R. Tocolysis with advanced cervical dilatation. Obstet Gynecol 2000; 95: 358-62.